Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device

Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device

Alternating electric field therapy has been approved for glioblastoma (GBM). We have preclinical evidence for anticancer effects in GBM cell cultures and mouse xenografts with an oscillating magnetic field (OMF) generating device. Here we report OMF treatment of end-stage recurrent glioblastoma in a...

Full description

Bibliographic Details
Main Authors: David S. Baskin, Martyn A. Sharpe, Lisa Nguyen, Santosh A. Helekar
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
magnetic resonance imaging
contrast enhanced tumor
compassionate use treatment
radiation-type tumor necrosis 2
oscillating magnetic fields
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.708017/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.708017/full

Similar Items